Lupin Resolves FDA’s Concerns on India Unit

Pharma company Lupin Ltd said it has addressed all concerns related to its manufacturing facility at Mandideep in Madhya Pradesh raised by the US health regulator Food and Drug Administration (FDA).
Business Standard